Anne Wojcicki, co-founder and former CEO of 23andMe, won a competitive bidding process to purchase the company for $305 million through her nonprofit, the TTAM Research Institute. The deal includes commitments to protect consumer privacy and data control, positioning the company to continue advancing genetic research and personalized health within a mission-driven framework.